Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia

NCT00623935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Fludarabine
DRUG: Busulfan
RADIATION: Total Body Irradiation
PROCEDURE: Stem Cell Transplant

Sponsor

University of Michigan Rogel Cancer Center